NMIH:NASDAQNMI Holdings Inc Analysis
Data as of 2026-05-28 - not real-time
$36.71
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
NMI Holdings is trading at $36.71, well below its 20‑day ($37.70), 50‑day ($38.33) and 200‑day ($38.52) simple moving averages, indicating a short‑term bearish price bias. The RSI of 39.5 and a bearish MACD histogram reinforce the downside momentum, while volume is trending lower, suggesting limited buying pressure. Despite this technical weakness, the stock’s PE of 7.46 versus an industry average of 16.5 and a DCF‑derived fair value of $65.37 point to a substantial valuation gap, with upside potential of roughly 25%. Recent earnings showed record revenue of $183.5 M (up 6% YoY) and adjusted EPS of $1.28, beating consensus estimates and highlighting strong underwriting profitability (gross margin ~76%). The company maintains robust operating (71.9%) and profit margins (53.8%) and generates solid free cash flow of $313 M, supporting its ability to service debt despite a high debt‑to‑equity ratio of 16.2. The balance sheet includes $96 M in cash, and the business benefits from low beta (0.42) and a defensive specialty‑insurance niche.
Given the disconnect between technical weakness and fundamental strength, the near‑term outlook suggests caution, but medium‑ to long‑term positioning appears attractive. The stock’s low dividend yield (0%) eliminates income considerations, while the “Extreme Greed” market sentiment may be inflating short‑term risk. Investors should monitor support at $35.83 and volume trends, but the combination of undervaluation, earnings beat, and high profitability supports a buy recommendation for horizons beyond the next few weeks.
Given the disconnect between technical weakness and fundamental strength, the near‑term outlook suggests caution, but medium‑ to long‑term positioning appears attractive. The stock’s low dividend yield (0%) eliminates income considerations, while the “Extreme Greed” market sentiment may be inflating short‑term risk. Investors should monitor support at $35.83 and volume trends, but the combination of undervaluation, earnings beat, and high profitability supports a buy recommendation for horizons beyond the next few weeks.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below key moving averages
- Bearish RSI and MACD signals
- Decreasing trading volume near support level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation upside vs DCF fair value
- Record revenue growth and earnings beat
- Strong operating and profit margins
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable high margins in specialty insurance
- Robust free cash flow generation
- Low beta indicating defensive stock characteristics
Key Metrics & Analysis
Financial Health
Revenue Growth5.90%
Profit Margin53.82%
P/E Ratio7.5
ROE15.57%
ROA8.86%
Debt/Equity16.17
P/B Ratio1.1
Op. Cash Flow$434.2M
Free Cash Flow$313.0M
Industry P/E16.5
Technical Analysis
TrendBearish
RSI39.5
Support$35.83
Resistance$40.92
MA 20$37.70
MA 50$38.33
MA 200$38.52
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88
Valuation
Fair Value$65.37
Target Price$46.14
Upside/Downside25.70%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.42
Volatility30.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.